Treatment of ischemia/reperfusion injury with thalidomide alone

Details Treatment of ischemia/reperfusion injury with thalidomide alone Treatment of ischemia/reperfusion injury with thalidomide alone

1995-06-06

1997-07-01

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514290, 514291, 514292, 514323, 514408, 514410, 514411, 514422, 514424, 514425, A01N 4342, A61K 3144, A61K 31445

Patent

active

056439156

ABSTRACT:
In accordance with the present invention, a method is provided for treating reperfusion injury, ischemia and runaway inflammatory conditions with thalidomide alone or in combination with other drugs selected from the group consisting of nitrates, beta-adrenoceptor blocking agents, anti-platelet/thrombolytic drugs, drugs acting as the arachindonic acid cascade and calcium antagonists. Pharmaceutical compositions comprising thalidomide alone or in combination with other drugs are also provided.

REFERENCES:
patent: 5434170 (1995-07-01), Andrulis, Jr.
patent: 5443824 (1995-08-01), Piacquadio

Affiliated with

Also associated with

Rating

Treatment of ischemia/reperfusion injury with thalidomide alone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ischemia/reperfusion injury with thalidomide alone , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ischemia/reperfusion injury with thalidomide alone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-597371